3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine

C104H136F12N34O12S6 — CID 161244117

About 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine

3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine (PubChem CID 161244117) has the molecular formula C104H136F12N34O12S6 and a molecular weight of 2474.84 g/mol. Its IUPAC name is 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine.

Molecular Properties

• Compound Name: 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine
• PubChem CID: 161244117
• Molecular Formula: C104H136F12N34O12S6
• Molecular Weight: 2474.84 g/mol
• Exact Mass: 2472.92
• IUPAC Name: 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine
• SMILES: CS(=O)(=O)c1c(C(F)(F)F)ccc(CC2(C3CCCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC(C3CCNCC3)C2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC3(CCCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC3(CCNC3)CC2)c1-c1nn[nH]n1.Cc1ccc(N2CCC(C)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC(C3CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O
• InChI: InChI=1S/C19H28N6O2S.2C18H23F3N6O2S.C18H21F3N4O2S.C17H21F3N6O2S.C14H20N6O2S/c1-13-7-8-16(17(18(13)28(20,26)27)19-21-23-24-22-19)25-11-9-15(10-12-25)14-5-3-2-4-6-14;1-30(28,29)15-12(18(19,20)21)3-4-13(14(15)16-23-25-26-24-16)27-9-6-17(7-10-27)5-2-8-22-11-17;1-30(28,29)16-13(18(19,20)21)2-3-14(15(16)17-23-25-26-24-17)27-9-6-12(10-27)11-4-7-22-8-5-11;1-28(26,27)15-13(18(19,20)21)7-6-11(14(15)16-22-24-25-23-16)10-17(8-9-17)12-4-2-3-5-12;1-29(27,28)14-11(17(18,19)20)2-3-12(13(14)15-22-24-25-23-15)26-8-5-16(6-9-26)4-7-21-10-16;1-9-5-7-20(8-6-9)11-4-3-10(2)13(23(15,21)22)12(11)14-16-18-19-17-14/h7-8,14-15H,2-6,9-12H2,1H3,(H2,20,26,27)(H,21,22,23,24);3-4,22H,2,5-11H2,1H3,(H,23,24,25,26);2-3,11-12,22H,4-10H2,1H3,(H,23,24,25,26);6-7,12H,2-5,8-10H2,1H3,(H,22,23,24,25);2-3,21H,4-10H2,1H3,(H,22,23,24,25);3-4,9H,5-8H2,1-2H3,(H2,15,21,22)(H,16,17,18,19)
• InChIKey: VAJZOLPSEIDEPF-UHFFFAOYSA-N
• XLogP: 13.72
• TPSA: 635.93 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 38
• Rotatable Bonds: 22
• Heavy Atoms: 168
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2474.84
LogP ≤ 5	13.72
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	38

Frequently Asked Questions

What is the IUPAC name of 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine?

The IUPAC name of 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine (CID 161244117) is 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine.

What is the SMILES notation for 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine?

The canonical SMILES for 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine is CS(=O)(=O)c1c(C(F)(F)F)ccc(CC2(C3CCCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC(C3CCNCC3)C2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC3(CCCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(N2CCC3(CCNC3)CC2)c1-c1nn[nH]n1.Cc1ccc(N2CCC(C)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.Cc1ccc(N2CCC(C3CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.

What is the InChIKey of 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine?

The InChIKey is VAJZOLPSEIDEPF-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H28N6O2S.2C18H23F3N6O2S.C18H21F3N4O2S.C17H21F3N6O2S.C14H20N6O2S/c1-13-7-8-16(17(18(13)28(20,26)27)19-21-23-24-22-19)25-11-9-15(10-12-25)14-5-3-2-4-6-14;1-30(28,29)15-12(18(19,20)21)3-4-13(14(15)16-23-25-26-24-16)27-9-6-17(7-10-27)5-2-8-22-11-17;1-30(28,29)16-13(18(19,20)21)2-3-14(15(16)17-23-25-26-24-17)27-9-6-12(10-27)11-4-7-22-8-5-11;1-28(26,27)15-13(18(19,20)21)7-6-11(14(15)16-22-24-25-23-16)10-17(8-9-17)12-4-2-3-5-12;1-29(27,28)14-11(17(18,19)20)2-3-12(13(14)15-22-24-25-23-15)26-8-5-16(6-9-26)4-7-21-10-16;1-9-5-7-20(8-6-9)11-4-3-10(2)13(23(15,21)22)12(11)14-16-18-19-17-14/h7-8,14-15H,2-6,9-12H2,1H3,(H2,20,26,27)(H,21,22,23,24);3-4,22H,2,5-11H2,1H3,(H,23,24,25,26);2-3,11-12,22H,4-10H2,1H3,(H,23,24,25,26);6-7,12H,2-5,8-10H2,1H3,(H,22,23,24,25);2-3,21H,4-10H2,1H3,(H,22,23,24,25);3-4,9H,5-8H2,1-2H3,(H2,15,21,22)(H,16,17,18,19).

What are the key properties of 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine?

3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine has a molecular weight of 2474.84 g/mol, XLogP of 13.72, 22 rotatable bonds, 11 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for 3-(4-cyclohexylpiperidin-1-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;5-[6-[(1-cyclopentylcyclopropyl)methyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;6-methyl-3-(4-methylpiperidin-1-yl)-2-(2H-tetrazol-5-yl)benzenesulfonamide;8-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,8-diazaspiro[4.5]decane;9-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]-2,9-diazaspiro[5.5]undecane;4-[1-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]pyrrolidin-3-yl]piperidine is sourced from PubChem (CID 161244117), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).